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Abstract
Background: Breast-preserving surgery (Bp) and sentinel lymph node biopsy (SNB) are established as standard
treatment for axillary lymph node-negative early breast cancer.
Methods: A surgical technique using manual blunt dissection (MBD), in which use of electrocautery, an
ultrasonically activated scalpel, and ligation is minimized, is described. This involves an approach from small
incisions in the axilla or areola to avoid injury to skin flaps, and with adequate mobilization of the breast, so that
regardless of the tumor site, surgical wounds are not noticeable. The usefulness and tolerability of this surgical
technique were examined.
Results: This surgical technique was evaluated in 233 patients. Surgery could be performed rapidly, with a mean
operative time of 67 ± 21 min and a low mean blood loss of only 35 ± 28 ml. There was little need for
postoperative analgesia, and surgery was well tolerated without postoperative bleeding or wound infection.
Conclusion: Our proposed technique for partial mastectomy using MBD provides good curative and cosmetic
results.
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Background
Breast-preserving surgery (Bp) and sentinel lymph node
biopsy (SNB) are established as standard treatment
for axillary lymph node-negative early breast cancer
[1–3]. With the addition of appropriate postoperative
radiotherapy, survival rates equivalent to mastectomy,
low recurrence in the preserved breast, and accept-
able treatment outcomes have been achieved [4–6].
New surgical techniques to maintain these cure rates
and provide good cosmetic results must now be
developed.
A surgical technique using manual blunt dissection
(MBD), in which use of electro cautery, an ultrasonically
activated scalpel, and ligation is minimized, is described.
It involves an approach from small incisions in the axilla
or areola to avoid injury to skin flaps, and with adequate
mobilization of the breast, so that regardless of the
tumor site, surgical wounds are not noticeable. The




This study included patients with primary breast cancer
that was confirmed preoperatively by needle biopsy be-
tween January 2010 and December 2012. Surgical out-
comes for 233 patients who underwent Bp + SNB at our
hospital are shown. The indications for this surgery were a
preoperative diagnosis of ductal carcinoma in situ (DCIS)
or tumor size ≤3 cm for invasive carcinoma, each without
clinical axillary node metastases (cN0) [2]. Lesion extent
was assessed by ultrasound and magnetic resonance im-
aging (MRI). For the mammary excision stump, a tumor
margin that was less than 5 mm was considered positive
and, in positive cases, a radiation boost of 10 Grays was
added. In addition, when there was marked denudation of
the cancer nest, re-excision was performed. Cosmesis was
evaluated after Bp using a patient-based tool, the “Four
points of evaluation of Harvard” [7].
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Axillary clearance was indicated for SN metastasis, de-
fined as macrometastasis (i.e., tumor diameter >2 mm)
in the SN. The presence of micrometastasis (i.e., tumor
diameter >0.2 mm, ≤2 mm, or <200 tumor cells) or
isolated tumor cells (ITCs, i.e., tumor diameter <0.2 mm
or <200 tumor cells) was not considered an indication for
axillary clearance [8].
This study was performed in accordance with the
Declaration of Helsinki and carried out with the approval
of the Ethical Review Board of Osaka City University
(#926). A sufficient explanation was provided, and written,
informed consent was obtained from all study subjects for
their involvement in this study and for the storage and use
of their data.
Surgical procedure
The target tumor was confirmed by palpation and ultra-
sound before surgery (solid line), and markings were
made at 1-cm margins on the skin directly above (dotted
line) the planned resection site (Fig. 1a). Lidocaine jelly
mixed with indigo carmine was percutaneously injected
along the markings (dotted line) into the breast surface
of the mammary gland (Fig. 1b), and about 40 mL of 1 %
lidocaine + epinephrine (3-fold dilution) were injected
subcutaneously around the planned area of dissection for
the purpose of hemostasis.
First, a 2-cm skin incision was made into the axilla for
SNB, and the sentinel lymph node (SN) was sent fresh
for intraoperative histopathology (Fig. 1c). The SN was
identified using radioisotope (RI) and staining methods
[9–13]. For the RI method, 1 millicurie (mCi)/mL of
99 m-technetium (Tc)-phytate colloid was injected intra-
dermally and subcutaneously directly above the tumor
and around the tumor on the day before surgery [14–16].
Lymphoscintigraphy was then performed to identify a
possible SN outside the axilla and search for the SN
during surgery. For the staining method, 5.0 mL of
indocyanine green (Diagnogreen; Daiichi Sankyo, Tokyo,
Japan) were injected subcutaneously to make a wheal in
the areola of the affected breast [17]. The area around the
injection was lightly massaged, and about 10 min later, a
skin incision was made to identify a green-stained lymph
node as the SN. The SN was removed, cut into 2-mm-
thick sections, and histopathologically examined by an
experienced pathologist. Only macrometastases were con-
sidered positive, whereas micrometastases and ITCs were
considered negative [8, 18, 19]. Patients with a positive SN
underwent further axillary lymph node dissection [20].
Next, a skin incision was made in the areola to per-
form a partial mastectomy (Fig. 1d). A crescent-like inci-
sion was made to expose the surgical field (an arc-like
incision was made in the breast margin for the tumor in
the outer upper region, and SNB + Bp were performed
from the same surgical wound). The skin around the
wound margin was grasped with sharp towel clamps,
and a 1 to 2-mm length of skin and subcutaneous fat
was dissected by electro cautery (Fig. 2a). Blunt subcuta-
neous dissection was performed using curved Cooper
scissors. The Cooper scissors were held with the tip to-
ward the skin side, and, with the tip closed, the tip was
slid along the back of the skin and pushed (Fig. 2b). Dis-
section of the planned area, including directly above the
Fig. 1 Surgical procedure of MBD (I). The target tumor was confirmed by palpation and ultrasound before surgery (a). Lidocaine jelly mixed with
indigo carmine was percutaneously injected (b). A 2-cm skin incision was made into the axilla for SNB (c). A skin incision was made in the areola
to perform a partial mastectomy (d)
Kashiwagi et al. BMC Surgery  (2015) 15:117 Page 2 of 5
tumor, proceeded in various directions. Using counter
traction with the towel clamps, the subcutaneous tis-
sue was dissected, being careful to avoid pulling of
the breast skin (Fig. 2c). With the procedure thus far,
only Cooper’s ligament remained, so Cooper’s liga-
ment was manually dissected, and the breast in the
planned area of dissection was completely mobilized
from the skin (Fig. 2d).
The breast was incised vertically along the markings
near the areola until the retromammary space was
reached, and then the retromammary space was manu-
ally dissected. This area was widely dissected to facilitate
breast flap mobilization after resection. While removing
the breast tissue through the surgical wound, dissection
proceeded along the markings for breast tumor resection
(Fig. 3a). Retention sutures were attached to the resected
Fig. 2 Surgical procedure of MBD (II). The skin around the wound margin was grasped with sharp towel clamps (a). Blunt subcutaneous
dissection was performed using curved Cooper scissors (b). Using counter traction with the towel clamps, the subcutaneous tissue was dissected
(c). The breast in the planned area of dissection was completely mobilized from the skin (d)
Fig. 3 Surgical procedure of MBD (III). Removing the breast tissue through the surgical wound (a). The resected tumor specimen was confirmed,
retention sutures were placed on the nipple side (b), and the breast margins were sutured and closed (c). The wound was closed with buried
subcuticular sutures (d)
Kashiwagi et al. BMC Surgery  (2015) 15:117 Page 3 of 5
tumor specimen so that the pathologists could under-
stand which was the nipple side at the time of patho-
logical diagnosis (Fig. 3b), and the breast margins were
sutured and closed (Fig. 3c). If any skin was being pulled
during suture closure, further subcutaneous dissection
in this area was performed to avoid pulling. The wound
was closed with buried subcuticular sutures and cyano-
acrylate adhesive applied to the skin. In principle, no
drains were placed (Fig. 3d).
Results
This surgical technique was evaluated in 233 patients.
Surgery could be rapidly performed, with a mean opera-
tive time of 67 (range 42–126, median 68, standard devi-
ation 21) min and a low mean blood loss of only 35
(range 1–136, median 33, standard deviation 28) ml.
Breast reconstruction by lateral tissue flap (LTF) was
done in 18 cases (7.7 %). Re-excision was performed in
five cases (2.1 %) to save tumor stump exposure. Macro-
metastasis was detected in 31 patients (13.3 %), and all
of these patients underwent axillary lymph node dissec-
tion. Micrometastasis was observed in 20 patients
(8.6 %). Cosmesis was evaluated as “Good” or better by
198 cases (85.0 %) (Excellent n = 86, Good n = 112, Fair
n = 29, Poor n = 6). There was little need for postopera-
tive analgesia, and surgery was well tolerated, with little
postoperative bleeding or wound infection (hematoma
n = 3, wound infection n = 1) (Table 1).
Discussion
Bp is minimally invasive and now considered standard
treatment for early breast cancer [1–3]. However, with a
partial mastectomy for tumor resection, some degree of
breast deformity is difficult to avoid, and patients may
be concerned about surgical scars of the breast skin. We
use an incision of the anterior axillary line or areola to
preserve skin directly above the tumor. In addition, for
any deformity due to breast resection, breast recon-
struction using residual breast and adipose tissue, or
simultaneous breast reconstruction using an autolo-
gous LTF or latissimus dorsi muscle flap (LDMF) can
be performed. This has provided excellent cosmetic
results [21, 22]. The results of the present study apply
to the small breasts of Japanese women, but, in the
case of larger breast patients or patients with ptosis,
MBD may be difficult when considering the distance
from the skin incision to the tumor.
Electrocautery and thermal cautery were previously
used for flap creation, but this often caused flap skin
damage or burn. However, MBD using Cooper scissors
can be used to quickly create a wide flap without skin
damage and thus reduce operative time. With wide flap
creation and adequate dissection of the retromammary
space, an axillary or areolar approach can be used for an
inconspicuous surgical scar, regardless of the tumor site.
Our surgical technique enables breast flap reconstruc-
tion without skin pulling to provide excellent cosmetic
results. In the present study, general anesthesia was
used, but MBD is thought to be possible under local
anesthesia [23].
Postoperative bleeding due to blunt dissection may be
a concern, but with adequate infiltration of 1 % lido-
caine + epinephrine (3-fold dilution), little postoperative
bleeding was noted with mild postoperative compression
with absorbent gauze.
Dissemination of cancer cells by tearing the tumor
may be considered when applying blunt dissection, so
our surgical technique is not indicated in patients with
suspected tumor infiltration into the skin. However,
because a subcutaneous skin flap with appropriate
layers can be created with minimal sharp dissection,
there is little or no risk of cutting into the tumor.
Surgeons at our institution have been performing this
surgical procedure since 2004, and no local recur-
rence due to our dissection technique has occurred.
Long-term evaluation in a larger number of cases,
however, would be desirable.
Conclusions
In conclusion, our proposed technique for partial mast-
ectomy using MBD provides good curative and cosmetic
results.
Table 1 Patient background and operation outcomes
Parameters Bp + SNB (n = 233)
Age (years) mean 59 (range 30–95, median 59, standard deviation 13)
Tumor diameter (cm) mean 2.0 (range 0.4–3.8, median 2.0, standard deviation 0.8)
Operation time (min) mean 67 (range 42–126, median 68, standard deviation 21)
Estimated blood loss (ml) mean 35 (range 1–136, median 33, standard deviation28)
Frequency of total analgesics mean 2.5
Cosmesis (Four points of evaluations of Harvard) Excellent 86, Good 112, Fair 29, Poor 6
Postoperative bleeding 3
Wound infection 1
Bp breast-preserving surgery, SNB sentinel lymph nodes biopsy
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